Hite Christopher

Track

Insider profile

Hite Christopher's trades of Royalty Pharma PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-02 2026-06-30
PlS Planned sale
63,855 +25.3%
35.73
US$934,206 		63,855 +25.3% 35.73 US$934,206
2026-07-02 2026-06-30
PlS Planned sale
37,248 +39.2%
111.43
US$571,793 		37,248 +39.2% 111.43 US$571,793
2026-07-02 2026-06-30
PlS Planned sale
98,145 +30.9%
447.13
US$4,993,864 		98,145 +30.9% 447.13 US$4,993,864
2026-07-02 2026-06-30
PlS Planned sale
97,446 -17.4%
56.50
US$5,505,972 		97,446 -17.4% 56.50 US$5,505,972
2026-06-25 2026-06-23
PlS Planned sale
117,592 -17.4%
54.47
US$6,405,777 		117,592 -17.4% 54.47 US$6,405,777
2026-06-25 2026-06-23
PlS Planned sale
32,408 -4.6%
54.11
US$1,753,500 		32,408 -4.6% 54.11 US$1,753,500
2026-06-23 2026-06-23
PrS Proposed sale
30,000
55.35
US$1,660,500 		30,000 55.35 US$1,660,500
2020-06-23 2020-06-18
B Purchase
70,000 +inf%
28.00
US$1,960,000 		70,000 +inf% 28.00 US$1,960,000